Ana Lucrecia Woodward

Array ( [id] => 5890045 [patent_doc_number] => 20060276485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/550222 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14497 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276485.pdf [firstpage_image] =>[orig_patent_app_number] => 10550222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256732 [patent_doc_number] => 20050143392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Chrysogenazine obtained from fungus Penicillium chrysogenum having antibacterial activity' [patent_app_type] => utility [patent_app_number] => 10/804201 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3476 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143392.pdf [firstpage_image] =>[orig_patent_app_number] => 10804201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410700 [patent_doc_number] => 20040176388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Piperazine derivatives as 5-HT1B antagonists' [patent_app_type] => new [patent_app_number] => 10/802236 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11879 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176388.pdf [firstpage_image] =>[orig_patent_app_number] => 10802236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337056 [patent_doc_number] => 20040132720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)' [patent_app_type] => new [patent_app_number] => 10/471432 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132720.pdf [firstpage_image] =>[orig_patent_app_number] => 10471432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435931 [patent_doc_number] => 07262188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Phenyl sulfone derivatives and their use in the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 10/547987 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3836 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262188.pdf [firstpage_image] =>[orig_patent_app_number] => 10547987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510688 [patent_doc_number] => 07196088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Substituted tetrahydroisoquinolines and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/791578 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11304 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196088.pdf [firstpage_image] =>[orig_patent_app_number] => 10791578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190702 [patent_doc_number] => 20040204423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Crystalline antifungal polymorph' [patent_app_type] => new [patent_app_number] => 10/786886 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5046 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204423.pdf [firstpage_image] =>[orig_patent_app_number] => 10786886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434642 [patent_doc_number] => 20040162430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity' [patent_app_type] => new [patent_app_number] => 10/783109 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6140 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162430.pdf [firstpage_image] =>[orig_patent_app_number] => 10783109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429035 [patent_doc_number] => 20040230056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Process for synthesizing N-aryl piperazines with chiral N\'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution' [patent_app_type] => new [patent_app_number] => 10/780972 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3735 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20040230056.pdf [firstpage_image] =>[orig_patent_app_number] => 10780972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463764 [patent_doc_number] => 07238696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands' [patent_app_type] => utility [patent_app_number] => 10/778427 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11175 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238696.pdf [firstpage_image] =>[orig_patent_app_number] => 10778427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7191842 [patent_doc_number] => 20040204586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same' [patent_app_type] => new [patent_app_number] => 10/778884 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 53017 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204586.pdf [firstpage_image] =>[orig_patent_app_number] => 10778884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040615 [patent_doc_number] => 06869913 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Pyridazin-3-one derivatives, their use and intermediates for their production' [patent_app_type] => utility [patent_app_number] => 10/773231 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102535 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869913.pdf [firstpage_image] =>[orig_patent_app_number] => 10773231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239137 [patent_doc_number] => 20040157854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'CCRS antagonists useful for treating aids' [patent_app_type] => new [patent_app_number] => 10/773521 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157854.pdf [firstpage_image] =>[orig_patent_app_number] => 10773521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265053 [patent_doc_number] => 20040242589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => '3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders' [patent_app_type] => new [patent_app_number] => 10/486068 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10314 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242589.pdf [firstpage_image] =>[orig_patent_app_number] => 10486068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276407 [patent_doc_number] => 20040235858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents' [patent_app_type] => new [patent_app_number] => 10/486025 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6068 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235858.pdf [firstpage_image] =>[orig_patent_app_number] => 10486025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912969 [patent_doc_number] => 20050176727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Oximes and hydrazones that are useful in treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 10/773035 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52101 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176727.pdf [firstpage_image] =>[orig_patent_app_number] => 10773035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606493 [patent_doc_number] => 07153858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Arylpiperazinyl compounds' [patent_app_type] => utility [patent_app_number] => 10/768579 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30338 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153858.pdf [firstpage_image] =>[orig_patent_app_number] => 10768579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672878 [patent_doc_number] => 20040180901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents' [patent_app_type] => new [patent_app_number] => 10/485675 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14964 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180901.pdf [firstpage_image] =>[orig_patent_app_number] => 10485675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5650036 [patent_doc_number] => 20060135771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Quinoline derivatives as nk-2 and nk-3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/542870 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13259 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135771.pdf [firstpage_image] =>[orig_patent_app_number] => 10542870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808371 [patent_doc_number] => 20060094726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Quinoline derivatives as nk-2 and nk-3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/542811 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11290 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094726.pdf [firstpage_image] =>[orig_patent_app_number] => 10542811 [rel_patent_id] =>[rel_patent_doc_number] =>)